Jo MD - RenovaCare Chief Officer

RCAR Stock  USD 0.0001  0.00  0.00%   

Insider

Jo MD is Chief Officer of RenovaCare
Phone888 398 0202
Webhttps://www.renovacareinc.com

RenovaCare Management Efficiency

The company has return on total asset (ROA) of (1.0399) % which means that it has lost $1.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.689) %, meaning that it created substantial loss on money invested by shareholders. RenovaCare's management efficiency ratios could be used to measure how well RenovaCare manages its routine affairs as well as how well it operates its assets and liabilities.
RenovaCare currently holds 800 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. RenovaCare has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RenovaCare until it has trouble settling it off, either with new capital or with free cash flow. So, RenovaCare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RenovaCare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RenovaCare to invest in growth at high rates of return. When we think about RenovaCare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Noel MBAPepGen
54
MD MBARezolute
N/A
CPA MBAPharvaris BV
63
David MackPmv Pharmaceuticals
62
Deepika PharmDPmv Pharmaceuticals
48
Anne LesagePharvaris BV
63
Kyle BreidenstinePepGen
N/A
Joan JDPharvaris BV
60
Hunter MDAerovate Therapeutics
58
LLM JDRezolute
63
Annick DeschoolmeesterPharvaris BV
51
James McArthurPepGen
62
Peter RhodeHCW Biologics
66
Fangyong DuAdagene
54
Niels SvenstrupPepGen
54
Brian MDRezolute
49
Jennifer CormierPepGen
N/A
Alexander ZurcherMolecular Partners AG
49
Man MBAAdagene
47
Scott AndersonAnebulo Pharmaceuticals
N/A
Leila MDPmv Pharmaceuticals
61
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. Renovacare operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people. RenovaCare [RCAR] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

RenovaCare Leadership Team

Elected by the shareholders, the RenovaCare's board of directors comprises two types of representatives: RenovaCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RenovaCare. The board's role is to monitor RenovaCare's management team and ensure that shareholders' interests are well served. RenovaCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RenovaCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Treasurer
Robin Robinson, VP Board
Harmel Rayat, Chairman of the Board
Alan Rubino, Consultant
Jo MD, Chief Officer

RenovaCare Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is RenovaCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with RenovaCare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RenovaCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovaCare will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to RenovaCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RenovaCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RenovaCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RenovaCare to buy it.
The correlation of RenovaCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RenovaCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RenovaCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RenovaCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for RenovaCare Pink Sheet Analysis

When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.